Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Intraventricular streptokinase infusion in acute post-haemorrhagic hydrocephalus.

Luciano R, Tortorolo L, Chiaretti A, Piastra M, Velardi F, Polidori G.

Intensive Care Med. 1998 May;24(5):526-9. Review.

PMID:
9660271
2.

Intraventricular streptokinase for the treatment of posthaemorrhagic hydrocephalus of preterm.

Yapicioğlu H, Narli N, Satar M, Soyupak S, Altunbaşak S.

J Clin Neurosci. 2003 May;10(3):297-9.

PMID:
12763331
3.

Intraventricular streptokinase after intraventricular hemorrhage in newborn infants.

Whitelaw A, Odd DE.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000498. Review.

PMID:
17943743
4.

Failure of fibrinolytic endoventricular treatment to prevent neonatal post-haemorrhagic hydrocephalus. A case-control trial.

Luciano R, Velardi F, Romagnoli C, Papacci P, De Stefano V, Tortorolo G.

Childs Nerv Syst. 1997 Feb;13(2):73-6.

PMID:
9105740
5.
6.
7.

Low dose intraventricular fibrinolytic treatment to prevent posthaemorrhagic hydrocephalus.

Whitelaw A, Rivers RP, Creighton L, Gaffney P.

Arch Dis Child. 1992 Jan;67(1 Spec No):12-4.

8.

Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?

Whitelaw A, Mowinckel MC, Abildgaard U.

Acta Paediatr. 1995 Aug;84(8):933-6.

PMID:
7488820
9.

Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus.

Hansen AR, Volpe JJ, Goumnerova LC, Madsen JR.

Pediatr Neurol. 1997 Oct;17(3):213-7.

PMID:
9390696
10.

[Thrombolytic therapy after intraventricular haemorrhage].

Gadegaard KH, Dahl BL, Hansen TS.

Ugeskr Laeger. 2010 May 10;172(19):1440-1. Danish.

PMID:
20470653
11.

Low dose intraventricular fibrinolytic treatment to prevent posthaemorrhagic hydrocephalus.

Corrigan JJ Jr.

Arch Dis Child. 1992 Jul;67(7 Spec No):886. No abstract available.

12.

Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus.

Hansen A, Whitelaw A, Lapp C, Brugnara C.

Acta Paediatr. 1997 Sep;86(9):995-8.

PMID:
9343282
13.

Intraventricular administration of recombinant tissue plasminogen activator for intraventricular hemorrhage in the newborn.

Akisu M, Yalaz M, Arslanoglu S, Kultursay N.

Neurosurg Rev. 2003 Oct;26(4):266-8. Epub 2003 Jun 11.

PMID:
12802693
14.

Intraventricular administration of human recombinant plasminogen activator for posthemorrhagic hydrocephalus of the newborn.

Nowak S, Rudecka M, Polis L.

Acta Paediatr. 1999 Mar;88(3):348-9. No abstract available.

PMID:
10229053
15.

Posthaemorrhagic ventricular dilatation: new mechanisms and new treatment.

Whitelaw A, Cherian S, Thoresen M, Pople I.

Acta Paediatr Suppl. 2004 Feb;93(444):11-4.

PMID:
15035455
16.

Phase I study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus.

Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N.

Arch Dis Child Fetal Neonatal Ed. 1996 Jul;75(1):F20-6.

18.

Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.

Mayfrank L, Kim Y, Kissler J, Delsing P, Gilsbach JM, Schröder JM, Weis J.

Acta Neuropathol. 2000 Nov;100(5):561-7.

PMID:
11045679
19.

Intraventricular streptokinase increases cerebrospinal fluid D dimer in preterm infants with posthaemorrhagic ventricular dilatation.

Whitelaw A, Mowinckel MC, Larsen ML, Røkås E, Abildgaard U.

Acta Paediatr. 1994 Mar;83(3):270-2.

PMID:
8038528
20.

[Ventricular haemorrhage in preterm neonates and posthemorrhagic hydrocephalus. Proposal of a management protocol based on early ventriculo-peritoneal shunt].

Ros-López B, Jaramillo-Dallimonti AM, De Miguel-Pueyo LS, Rodríguez-Barceló S, Domínguez-Páez M, Ibáñez-Botella G, Márquez-Márquez B, Arráez-Sánchez MA.

Neurocirugia (Astur). 2009 Feb;20(1):15-24. Spanish.

Supplemental Content

Support Center